GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain

Purpose: The present study assessed the effects of the GABAA receptor (R) agonist muscimol (MUS), and the GABAAR antagonist bicuculline (BIC) on neocortical and subcortical radioligand binding to dopamine D2/3Rs in relation to motor and exploratory behaviors in the rat.Methods: D2/3R binding was mea...

Full description

Bibliographic Details
Main Authors: Susanne Nikolaus, Hans-Jörg Wittsack, Markus Beu, Christina Antke, Maria A. De Souza Silva, Frijthof Wickrath, Anja Müller-Lutz, Joseph P. Huston, Gerald Antoch, Hans-Wilhelm Müller, Hubertus Hautzel
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnbeh.2018.00038/full
id doaj-189a1d6f30594548a954aa83ddc9b471
record_format Article
spelling doaj-189a1d6f30594548a954aa83ddc9b4712020-11-25T00:23:31ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532018-03-011210.3389/fnbeh.2018.00038336265GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat BrainSusanne Nikolaus0Hans-Jörg Wittsack1Markus Beu2Christina Antke3Maria A. De Souza Silva4Frijthof Wickrath5Anja Müller-Lutz6Joseph P. Huston7Gerald Antoch8Hans-Wilhelm Müller9Hubertus Hautzel10Clinic of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, GermanyDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University Düsseldorf, Düsseldorf, GermanyClinic of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, GermanyClinic of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, GermanyCenter for Behavioural Neuroscience, Institute of Experimental Psychology, Heinrich-Heine University, Düsseldorf, GermanyDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University Düsseldorf, Düsseldorf, GermanyDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University Düsseldorf, Düsseldorf, GermanyCenter for Behavioural Neuroscience, Institute of Experimental Psychology, Heinrich-Heine University, Düsseldorf, GermanyDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University Düsseldorf, Düsseldorf, GermanyClinic of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, GermanyClinic of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, GermanyPurpose: The present study assessed the effects of the GABAA receptor (R) agonist muscimol (MUS), and the GABAAR antagonist bicuculline (BIC) on neocortical and subcortical radioligand binding to dopamine D2/3Rs in relation to motor and exploratory behaviors in the rat.Methods: D2/3R binding was measured with small animal SPECT in baseline and after challenge with either 1 mg/kg MUS or 1 mg/kg BIC, using [123I]IBZM as radioligand. Motor/exploratory behaviors were assessed for 30 min in an open field prior to radioligand administration. Anatomical information was gained with a dedicated small animal MRI tomograph. Based on the Paxinos rat brain atlas, regions of interest were defined on SPECT-MRI overlays. Estimations of the binding potentials in baseline and after challenges were obtained by computing ratios of the specifically bound compartments to the cerebellar reference region.Results: After MUS, D2/3R binding was significantly reduced in caudateputamen, nucleus accumbens, thalamus, substania nigra/ventral tegmental area, and posterior hippocampus relative to baseline (0.005 ≤ p ≤ 0.012). In all these areas, except for the thalamus, D2/3R binding was negatively correlated with grooming in the first half and positively correlated with various motor/exploratory behaviors in the second half of the testing session. After BIC, D2/3R binding was significantly elevated in caudateputamen (p = 0.022) and thalamus (p = 0.047) relative to baseline. D2/3R binding in caudateputamen and thalamus was correlated negatively with sitting duration and sitting frequency and positively with motor/exploratory behaviors in the first half of the testing time.Conclusions: Findings indicate direct GABAergic control over nigrostriatal and mesolimbic dopamine levels in relation to behavioral action. This may be of relevance for neuropsychiatric conditions such as anxiety disorder and schizophrenia, which are characterized by both dopaminergic and GABAergic dysfunction.http://journal.frontiersin.org/article/10.3389/fnbeh.2018.00038/fullD2/3 receptor[123I]IBZMGABAA receptormuscimolbicuculline
collection DOAJ
language English
format Article
sources DOAJ
author Susanne Nikolaus
Hans-Jörg Wittsack
Markus Beu
Christina Antke
Maria A. De Souza Silva
Frijthof Wickrath
Anja Müller-Lutz
Joseph P. Huston
Gerald Antoch
Hans-Wilhelm Müller
Hubertus Hautzel
spellingShingle Susanne Nikolaus
Hans-Jörg Wittsack
Markus Beu
Christina Antke
Maria A. De Souza Silva
Frijthof Wickrath
Anja Müller-Lutz
Joseph P. Huston
Gerald Antoch
Hans-Wilhelm Müller
Hubertus Hautzel
GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
Frontiers in Behavioral Neuroscience
D2/3 receptor
[123I]IBZM
GABAA receptor
muscimol
bicuculline
author_facet Susanne Nikolaus
Hans-Jörg Wittsack
Markus Beu
Christina Antke
Maria A. De Souza Silva
Frijthof Wickrath
Anja Müller-Lutz
Joseph P. Huston
Gerald Antoch
Hans-Wilhelm Müller
Hubertus Hautzel
author_sort Susanne Nikolaus
title GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
title_short GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
title_full GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
title_fullStr GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
title_full_unstemmed GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
title_sort gabaergic control of nigrostriatal and mesolimbic dopamine in the rat brain
publisher Frontiers Media S.A.
series Frontiers in Behavioral Neuroscience
issn 1662-5153
publishDate 2018-03-01
description Purpose: The present study assessed the effects of the GABAA receptor (R) agonist muscimol (MUS), and the GABAAR antagonist bicuculline (BIC) on neocortical and subcortical radioligand binding to dopamine D2/3Rs in relation to motor and exploratory behaviors in the rat.Methods: D2/3R binding was measured with small animal SPECT in baseline and after challenge with either 1 mg/kg MUS or 1 mg/kg BIC, using [123I]IBZM as radioligand. Motor/exploratory behaviors were assessed for 30 min in an open field prior to radioligand administration. Anatomical information was gained with a dedicated small animal MRI tomograph. Based on the Paxinos rat brain atlas, regions of interest were defined on SPECT-MRI overlays. Estimations of the binding potentials in baseline and after challenges were obtained by computing ratios of the specifically bound compartments to the cerebellar reference region.Results: After MUS, D2/3R binding was significantly reduced in caudateputamen, nucleus accumbens, thalamus, substania nigra/ventral tegmental area, and posterior hippocampus relative to baseline (0.005 ≤ p ≤ 0.012). In all these areas, except for the thalamus, D2/3R binding was negatively correlated with grooming in the first half and positively correlated with various motor/exploratory behaviors in the second half of the testing session. After BIC, D2/3R binding was significantly elevated in caudateputamen (p = 0.022) and thalamus (p = 0.047) relative to baseline. D2/3R binding in caudateputamen and thalamus was correlated negatively with sitting duration and sitting frequency and positively with motor/exploratory behaviors in the first half of the testing time.Conclusions: Findings indicate direct GABAergic control over nigrostriatal and mesolimbic dopamine levels in relation to behavioral action. This may be of relevance for neuropsychiatric conditions such as anxiety disorder and schizophrenia, which are characterized by both dopaminergic and GABAergic dysfunction.
topic D2/3 receptor
[123I]IBZM
GABAA receptor
muscimol
bicuculline
url http://journal.frontiersin.org/article/10.3389/fnbeh.2018.00038/full
work_keys_str_mv AT susannenikolaus gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT hansjorgwittsack gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT markusbeu gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT christinaantke gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT mariaadesouzasilva gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT frijthofwickrath gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT anjamullerlutz gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT josephphuston gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT geraldantoch gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT hanswilhelmmuller gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
AT hubertushautzel gabaergiccontrolofnigrostriatalandmesolimbicdopamineintheratbrain
_version_ 1725356583742865408